MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.
She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.
MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.
The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.
On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."
The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.
This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.
A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.
These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.
Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:
The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.
It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.
In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.
This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.
Credit: X/iStock
The Ebola Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is showing early signs of slowing in some areas, WHO Director-General Tedros Adhanom Ghebreyesus said on Wednesday.
Speaking at a hybrid press briefing, Tedros said there were “encouraging signs” that the response was gaining ground, while warning that the epidemic continues to grow and cause deaths.
“We are now starting to see encouraging signs that we are gaining ground.”
According to Tedros, transmission is declining in some of the worst-affected parts of Ituri province.
Other signs of progress include:
Not yet. Tedros stressed that the “epidemic continues to grow, and continues to kill.”
More than 7,200 cases and over 3,500 deaths have been reported across seven provinces.
Although transmission has declined in parts of Ituri, it is falling from a high level. In the past week alone, around 300 new cases and 160 deaths were reported from Ituri, accounting for nearly half the national total, the WHO chief said.
In North Kivu, meanwhile, cases are rising rapidly. Over the past two weeks, the number of weekly cases has almost doubled, from about 100 to more than 200.
“The area is so vast that it is hard to speak of a single epidemic. It is many outbreaks, in many places. We must get the response right in every one of them,” Dr Tedros said.
Read More: 1 In 60 Adults In Fiji May Now Have HIV As Meth Use, Unsafe Injecting And Treatment Gaps Fuel Surge
Last week, Congolese Health Minister Samuel Roger Kamba said transmission of the Bundibugyo virus had declined, with daily cases falling from about 120 at the peak in mid-August to around 80.
“We are fighting a very dangerous virus that is killing many of our people. Today, we can say that the outbreak is under control,” he said.
“At one point, we were recording about 120 cases per day; today, we’re seeing about 80 per day. So the number of new cases is decreasing every day.”
Kamba said 10 of the 62 affected health zones had reported no new cases for more than 22 days. Six health zones had gone more than 42 days without a new case, while four had gone more than 21 days without one.
He described the figures as “encouraging” but stressed that people must remain fully mobilized and not lower their guard.
The outbreak, caused by the rare Bundibugyo virus, was declared by the WHO on May 15. It is the DRC’s 17th Ebola outbreak since the virus was first identified in 1976.
It is also the second-deadliest Ebola outbreak on record, behind the West African outbreak that lasted from 2014 to 2016.
Clinical trials of vaccines and treatments against the Bundibugyo virus are ongoing. The DRC also received more than 70,000 doses of the Ervebo vaccine last month. Ervebo is approved for protection against the more common Zaire Ebola virus.
Credit: Instagram
US President Donald Trump has nominated Dr Nicole Saphier to serve as US Surgeon General, making her the third person he has chosen for the position.
Saphier’s nomination comes after Trump withdrew the nomination of Dr Casey Means in April after her confirmation stalled in the Senate. Trump had earlier withdrawn his first nominee, Fox News medical contributor Dr Janette Nesheiwat, following questions over her academic credentials.
Saphier will need to be confirmed by the Senate before she can take up the position. She is appearing before the Senate Health, Education, Labor and Pensions (HELP) Committee on Wednesday for her confirmation hearing.
Saphier is the director of breast imaging at Memorial Sloan Kettering Monmouth, according to her profile on the New York-based cancer centre’s website. She earned her medical degree from Ross University School of Medicine in Barbados and completed fellowships at Mayo Clinic, according to the profile.
She is also a former Fox News contributor and has been a public voice on issues including breast cancer prevention, COVID-19 policies, vaccines and chronic disease.
“Dr. Nicole Saphier is an accomplished physician who has practiced radiology at Memorial Sloan-Kettering and has been an outspoken voice on breast cancer prevention, intrusive COVID-19 mandates, the politicization of science, and the federal government’s role in America’s chronic disease epidemic,” White House spokesman Kush Desai said in a statement.
“She has been a powerful asset for President Trump and works tirelessly to deliver on every facet of his MAHA agenda,” Desai added.
Read More: Meet Heidi Overton: Trump Set to Nominate White House Adviser to Lead FDA
While senators may scrutinise Saphier’s credentials and professional background, she is also expected to face questions about how she would navigate Health Secretary Robert F. Kennedy Jr.’s public-health policies if confirmed.
Vaccination policy is likely to be a major focus. The administration has moved to reconsider aspects of federal vaccine guidance, while measles outbreaks have raised concerns among public-health experts.
Lawmakers from both parties have criticised Kennedy’s positions on vaccines, and senators are expected to question Saphier about whether she would take a stronger stance in support of vaccination if confirmed.
Saphier has questioned the need for every newborn to receive the hepatitis B vaccine at birth, a longstanding recommendation that the Trump administration has also sought to change.
At the same time, she has disagreed with Trump and Kennedy on some health issues. In an interview with The Associated Press last year, she said Trump’s warnings about pregnant women taking Tylenol were oversimplistic and “patronizing.”
Also read: Dr. Erica Schwartz Confirmed As CDC’s First Permanent Director In Nearly A Year
Saphier also has a significant social-media presence, with about 147,000 followers on Instagram. Her profile identifies her as the creator of DropRx, a brand of liquid herbal supplements.
According to her financial disclosure and ethics forms, Saphier will divest holdings in a range of companies, including those in the food, soda and pharmaceutical industries.
Her ethics agreement also states that, if confirmed by the Senate, she will resign from DropRx, her dietary and herbal supplement company, and Empower MD, which owns DropRx.
Vaccination policy is expected to be a major focus of Saphier’s confirmation hearing.
Senators are also expected to question the nominees about the cancellation of government grants and the US opioid crisis.
Saphier is appearing before the HELP Committee alongside Chris Klomp, Trump's nominee for Deputy Secretary of Health and Human Services, and Timothy Westlake, his pick to lead the Substance Abuse and Mental Health Services Administration.
Credit: AI
Fiji has declared a national HIV emergency after recent reports and estimates showed that around one in every 60 adults may now be living with HIV.
The estimate has sparked concern as it marks a sharp rise from about one in 167 adults five years ago.
Fiji recorded more than 2,000 new HIV diagnoses in 2025. Health officials have attributed the grim development to unsafe injecting practices, lack of sterile equipment and major gaps in HIV treatment and prevention.
Health Minister Dr Atonio Lalabalavu said the scale and reach of the epidemic required a response that is more effective than existing outbreak measures.
“The findings also show the seriousness of the epidemic and the gaps we must close in prevention, treatment and continuing care. We have acted on that evidence. An outbreak-level response is no longer sufficient. The Ministry of Health cannot meet this challenge alone. It requires coordinated action across Government, alongside communities and our partners.”
Health officials and HIV experts have identified injectable drug use, especially meth, as a major driver of the current surge.
The concern is not methamphetamine abuse itself transmitting HIV. The risk arises when people who inject drugs share needles and syringes to ingest the drugs.
Dr Jason Mitchell, chair of Fiji’s National HIV Outbreak and Cluster Response Taskforce, said, “Fiji is currently navigating the fastest-growing HIV epidemic in the world, and what is driving this epidemic now is risky injecting drug use of people who currently inject methamphetamines.”
He added, “The unavailability of sterile needles and syringes has resulted in people who use drugs sharing needles, syringes and drug-mixing equipment.”
UNAIDS has previously highlighted the scale of the change. It reported that new HIV infections in Fiji had increased tenfold since 2014, while only 36% of people living with HIV were estimated to know their status in 2024 and just 24% were receiving treatment.
Also read: Thailand’s HIV Cases Cross 550,000 In 2026; Over 25,000 Among 15–24s
Finding people with HIV is only the first step. They need to remain connected to treatment to contain transmission.
Recent reports found that the proportion of diagnosed people receiving antiretroviral therapy had fallen from more than 98% before 2021 to around 56%.
“We are now finding people faster than we are able to keep them in care,” Mitchell said.
Antiretroviral therapy suppresses HIV in the body and allows people living with HIV to lead long, healthy lives.
When treatment reduces the virus to an undetectable level, people do not sexually transmit HIV, a principle known as U=U, or undetectable equals untransmittable.
The government says its response will include expanded HIV testing and treatment, greater access to pre-exposure prophylaxis (PrEP) and the introduction of a formal needle and syringe programme.
It also plans to strengthen its follow-up care system so people diagnosed with HIV remain connected to treatment.
The emergency declaration comes as HIV prevalence among women attending antenatal care has reached around 2%, or about one in 50 pregnant women.
That figure raises the concern of mother-to-child transmission. HIV can be transmitted during pregnancy, childbirth or breastfeeding, but effective treatment and preventive care can dramatically reduce this risk.
© $2026 Times Horizon Private Limited